197 related articles for article (PubMed ID: 18486055)
21. Linezolid.
Tuberculosis (Edinb); 2008 Mar; 88(2):122-5. PubMed ID: 18486048
[No Abstract] [Full Text] [Related]
22. Moxifloxacin.
Tuberculosis (Edinb); 2008 Mar; 88(2):127-31. PubMed ID: 18486050
[No Abstract] [Full Text] [Related]
23. SQ109.
Tuberculosis (Edinb); 2008 Mar; 88(2):159-61. PubMed ID: 18486060
[No Abstract] [Full Text] [Related]
24. Harnessing the full sterilising activity of rifamycins.
Leung CC; Yew WW; Grosset J
Int J Tuberc Lung Dis; 2011 Apr; 15(4):429-30. PubMed ID: 21396197
[No Abstract] [Full Text] [Related]
25. [Comparative results of the therapeutic action of morphazinamide and pyrazinamide combined with ethionamide in experimental tuberculosis in guinea pigs].
Rözewska M
G Ital Chemioter; 1967; 14(1):49-57. PubMed ID: 5622725
[No Abstract] [Full Text] [Related]
26. Pyrazinamide--on the antituberculosis drug frontline.
Mitchison DA
Nat Med; 1996 Jun; 2(6):635-6. PubMed ID: 8640549
[No Abstract] [Full Text] [Related]
27. [Antitubercular properties of some derivatives of pyrazine carboxylic acid].
Solov'ev VN; Pavolo EP
Farmakol Toksikol; 1967; 30(6):734-7. PubMed ID: 4970686
[No Abstract] [Full Text] [Related]
28. Tuberculostatic activity of N-morpholino-4'-méthylamide pyrazincarbonic acid on experimental tuberculosis in mice.
Verbist L
Acta Tuberc Pneumol Belg; 1966; 57(3):211-7. PubMed ID: 5985965
[No Abstract] [Full Text] [Related]
29. Tuberculosis and pregnancy.
Singla R
Indian J Chest Dis Allied Sci; 2004; 46(4):299; author reply 299-300. PubMed ID: 15515833
[No Abstract] [Full Text] [Related]
30. [The antitubercular activity of a pyrazinamide derivative: morphazinamide].
Grassi C
Acta Tuberc Pneumol Belg; 1966; 57(3):196-210. PubMed ID: 4862621
[No Abstract] [Full Text] [Related]
31. TMC-207.
Tuberculosis (Edinb); 2008 Mar; 88(2):168-9. PubMed ID: 18486063
[No Abstract] [Full Text] [Related]
32. Gatifloxacin.
Tuberculosis (Edinb); 2008 Mar; 88(2):109-11. PubMed ID: 18486044
[No Abstract] [Full Text] [Related]
33. Anti-Tubercular Activity of Pyrazinamide Conjugates: Synthesis and Structure-Activity Relationship Studies.
Wahan SK; Sharma S; Chawla PA
Mini Rev Med Chem; 2023; 23(6):700-718. PubMed ID: 35986542
[TBL] [Abstract][Full Text] [Related]
34. Management of latent tuberculosis infection in immigrants.
Sterling T; Munsiff SS; Frieden TR
N Engl J Med; 2003 Mar; 348(13):1289-92; author reply 1289-92. PubMed ID: 12661573
[No Abstract] [Full Text] [Related]
35. [Comparison of the effect of morphazinamide and pyrazinamide in the treatment of chronic tuberculosis].
Zierski M
Gruzlica; 1965 Sep; 33(9):769-71. PubMed ID: 5859903
[No Abstract] [Full Text] [Related]
36. [Experimental therapy with so-called "minor" tuberculostatics].
Freerksen E
Wien Med Wochenschr; 1966 Oct; 116(42):874-7. PubMed ID: 6005730
[No Abstract] [Full Text] [Related]
37. Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide.
Fyfe PK; Rao VA; Zemla A; Cameron S; Hunter WN
Angew Chem Int Ed Engl; 2009; 48(48):9176-9. PubMed ID: 19859929
[No Abstract] [Full Text] [Related]
38. Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs.
Chung WJ; Kornilov A; Brodsky BH; Higgins M; Sanchez T; Heifets LB; Cynamon MH; Welch J
Tuberculosis (Edinb); 2008 Sep; 88(5):410-9. PubMed ID: 18674969
[TBL] [Abstract][Full Text] [Related]
39. Activity of pyrazinamide in the guinea pig model of tuberculosis.
Mitchison DA
Antimicrob Agents Chemother; 2010 Dec; 54(12):5420. PubMed ID: 21075978
[No Abstract] [Full Text] [Related]
40. Novel drug combination for tuberculosis to be tested across 50 sites.
Bagcchi S
BMJ; 2014 May; 348():g3535. PubMed ID: 24868091
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
